Role of surgery in patients with early stage small-cell lung cancer [Erratum]

This article refers to:

Role of surgery in patients with early stage small-cell lung cancer

Peng A, Li G, Xiong M, et al. Cancer Manag Res. 2019;11:7089–7101.

On page 7094, Table 2 should be presented as follows:

Table 2 Multivariate analysis using a cox proportional hazards model in patients with early stage SCLC

Variable	Multivariable analysis^a
HR	95% CI	P
Age, year			<0.001
<45	Reference
≥45, <55	4.961	1.208–20.374	0.026
≥55, <65	5.008	1.238–20.257	0.024
≥65, <75	5.618	1.391–22.681	0.015
≥75	7.381	1.824–29.870	0.005
Sex			0.008
Female	Reference
Male	1.201	1.050–1.374
Tumor size, cm			0.002
≤1	Reference
>1, ≤2	1.180	0.868–1.604	0.292
>2, ≤3	1.217	0.893–1.658	0.213
>3, ≤4	1.346	0.975–1.858	0.071
>4, ≤5	1.770	1.268–2.471	0.001
Unknown	1.192	0.163–8.735	0.863
Surgery			<0.001
No	Reference
Yes	0.499	0.420–0.594
Radiotherapy			<0.001
No	Reference
Yes	0.552	0.411–0.742
Chemotherapy			0.942
No	Reference
Yes	0.993	0.822–1.200
Adjuvant therapy			0.839
None	Reference
Chemoradiotherapy	1.035	0.742–1.445
Insurance status			0.495
Medicaid	Reference
Uninsured	1.288	0.724–2.290	0.390
Unknown	0.869	0.621–1.215	0.411
Insured	0.900	0.709–1.142	0.386
Year of diagnosis			<0.001
2004–2007	Reference
2008–2011	1.255	0.975–1.617	0.078
2012–2015	2.371	1.828–3.075	<0.001

Notes: ^amultivariate analysis for age, sex, tumor size, surgery, radiotherapy, chemotherapy, insurance status, adjuvant therapy and year of diagnosis.

Abbreviations: SCLC, small-cell lung cancer; HR, hazard ratio; CI, confidence interval.

Following a review of the data post-publication, the authors found Table 2 was misaligned. This replacement of Table 2 has no impact to the findings of the study.